Author: Kathir J

AOULINK, a flagship decentralized finance ecosystem that has undergone thorough auditing and strategic alignment by the global AICG governance hub, Interstellar Alliance, officially launched globally on May 5, 2026 at 19:00 (UTC+8) / 11:00 (GMT).

As a decentralized infrastructure that deeply integrates “high-performance transactional infrastructure” and “full-scenario financial modules”, the launch of AOULINK marks the official departure of on-chain interaction from inefficient and fragmented discrete protocol games, and the entry into a “standardized growth” stage protected by institutional-level audit standards.

The Project Evaluation Center (PEC) of the Interstellar Alliance utilized the FERGS penetrating audit framework to conduct a multi-dimensional assessment of AOULINK’s underlying logic and business efficiency. The audit results show that AOULINK possesses significant generational advantages in asset certainty and growth logic:

Algorithm-driven sustainability: an endogenous reward mechanism that rejects short-term stimulus (Fundamentals)

AOULINK has fundamentally restructured the revenue order of traditional platforms. Based on the FERGS sustainability audit criteria, AOULINK enforces a 90/10 profit distribution agreement: 90% of the core value generated by the system, such as transaction fees, funding rates, and liquidation proceeds, is directly returned to liquidity providers (LPs) through immutable smart contracts. This “endogenous profitability” logic ensures that the ecosystem does not rely on short-term market subsidies or single-ecosystem growth, possessing extremely strong cross-cycle operation capabilities and long-term stability.

Full-scenario integrated execution capabilities: Deterministic delivery based on real-world application paths (Execution)

Unlike the common protocol patchwork model in the market, the AOULINK team has demonstrated a strong certainty of commercialization. The ecosystem comprises modules covering all scenarios, including perpetual contracts, lending systems, hedging and quantitative strategies, and a community ecosystem. This deep integration of “foundation + self-operated applications” significantly reduces the losses from cross-protocol interactions, proving the team’s closed-loop delivery capability from top-level design to end-user execution, and a clear value-driven path.

Physical-level access control for fund security: Risk isolation and self-control system (Risk)

Security is the fundamental red line of AOULINK’s asset architecture. The ecosystem’s built-in risk hedging quantitative engine captures external market arbitrage opportunities in real time, smooths internal position imbalances, and establishes the asset’s hedging capabilities in extreme market environments. Simultaneously, AOULINK adheres to the physical logic of “private key self-holding,” ensuring clear and transparent fund flows with physical-level access control mechanisms. This fundamentally eliminates the credit default risks of traditional centralized custody, ensuring assets are securely controlled within the rules.

The scalability of mechanisms under global collaboration: a growth model that can be replicated across regions

As a flagship project in the Web3 finance sector selected by the Interstellar Alliance, AOULINK has secured strategic collaboration with top 100 core teams globally. Through standardized, industrialized execution pathways, AOULINK’s consensus mechanism and business logic can be efficiently transmitted across four continents: Asia, Europe, North America, and South America. This mechanism does not rely on local resources but achieves exponential scaling across groups and regions through standardized operating procedures (SOPs), establishing extremely strong value potential.

Market absorption capacity of high-performance bases: supporting the steady-state (scale) of systems with large-scale, high-frequency interactions

Addressing the latency issues commonly found in on-chain finance, AOULINK has achieved millisecond-level response times by reconstructing the physical execution layer. This high-performance transactional public chain foundation ensures that the system maintains stable revenue distribution and conversion efficiency even when facing large-scale user onboarding and extremely high concurrency interactions. Audits have verified that AOULINK has the throughput capacity to support diverse global markets, ensuring that the overall ecosystem operates smoothly and without instability during large-scale expansion.

About the Interstellar Alliance

Interstellar Alliance is the world’s first value collaboration system driven by AICG (Intelligent Co-governance). By codifying governance logic and digitizing decision-making processes, the Alliance connects with top-tier global strategic capital firms (such as Standard Crypto, ParaFi Capital, and DCG), aiming to reshape the business order in the digital age. Leveraging six functional centers and a global team of 100 executives, the Alliance seeks to eliminate the efficiency losses caused by discrete game theory, providing global value seekers with project selection, risk control, and growth pathways.

About AOULINK

AOULINK is a decentralized finance ecosystem built on a high-performance transactional public blockchain, integrating perpetual contracts, lending, hedging quantitative strategies, and a community ecosystem. It aims to construct a transparent, secure, and sustainable decentralized value ecosystem network through technological innovation and mechanism restructuring.

New York, NY – 04/05/2026 – (SeaPRwire) – TaxiNexo, an AI-powered mobility company, recently announced that it began its global strategy years ago, aiming to bring autonomous taxis to major cities worldwide. Currently, the company has already launched autonomous taxi services in New York City and achieved initial success.

TaxiNexo continues to expand its autonomous driving network. Following New York, the company will soon officially launch its autonomous taxi service in Los Angeles, further expanding its presence in its key US markets.

In addition to the cities already mentioned, TaxiNexo is also targeting other major American cities, including Washington, D.C., San Francisco, and Atlanta, planning to gradually advance testing and commercial operation of autonomous vehicles to build a national smart mobility network.

The company stated that its autonomous taxi system, based on an AI-powered dispatch platform and autonomous driving technology, can achieve efficient operation and continuous optimization. In high-frequency urban travel scenarios, this model is expected to improve traffic efficiency and provide users with a more convenient travel experience.

The company has long invested in research and development of autonomous driving technology and its expansion into the global market, aiming not only to enter a single city but also to create an autonomous mobility ecosystem spanning multiple cities and countries.

In its future development strategy, the company aims to become the world’s largest autonomous vehicle operation and rental company and promote the global adoption of autonomous mobility services.

Media contact

Brand: TaxiNexo

Contact: Media team

Email: suport@taxinexo.com

Website: https://www.taxinexo.com

Limassol, Cyprus – 04/05/2026 – (SeaPRwire) – Vaiz, a Cyprus-based work management platform, is growing its user base with a product principle most competitors ignore: zero employee surveillance. The platform has no keystroke logging, no screenshot capture, no mouse tracking, and no automatic activity monitoring. It is a deliberate product decision, not a missing feature.

Vaiz combines tasks, documents, and team collaboration in one workspace — without any form of employee activity tracking.

The announcement comes as workplace monitoring faces renewed criticism. In April 2026, a major technology company began installing software on employee computers to record keystrokes, mouse movements, and screen activity to train AI models. The decision triggered immediate employee backlash and public debate about the limits of employer surveillance. A growing number of teams are now looking for tools that help them coordinate work without tracking how people spend every minute.

Why no-surveillance work management matters now

Employee monitoring software has grown from a niche practice to a global norm. Adoption rose from 30 percent before the pandemic to 60 percent by 2022. In 2026, the EU AI Act classifies workplace AI monitoring as high-risk and restricts practices such as emotion recognition in employment, with penalties up to 35 million euros or 7 percent of global revenue.

Research shows that 31 percent of monitored employees feel micromanaged, and 23 percent report a sense of constant surveillance. For small and mid-sized teams that depend on trust and speed, surveillance tools often cause more harm than the problems they claim to solve. Vaiz was designed for these teams. The platform does not include any automatic activity tracking, screen recording, or behavioural monitoring.

What Vaiz offers instead of surveillance

Vaiz is a unified work management platform that brings tasks, documents, files, and team discussions into a single workspace. Rather than tracking employee behaviour, the platform makes work visible through structure: task boards, project timelines, milestones, and shared documents that give everyone context without oversight software.

The platform connects to over 2,000 applications through Zapier and offers native integrations with Slack, GitHub, and GitLab. Embedded tools include Figma, Miro, YouTube, Vimeo, Swagger, and GraphQL editors. A built-in AI assistant turns goals into task breakdowns, generates project plans, summarises discussions into action items, and improves document clarity. A native MCP server connects Vaiz to AI assistants such as Claude and Cursor, and three public SDKs let developers extend the platform. The full list is available on the integrations page.

Vaiz co-founder Konstantin Cherkasov explained the company’s position: “We build tools that help teams coordinate their work, not tools that watch people. If a platform needs to capture your screen to know whether you are productive, the problem is not the employee — it is the platform.”

Switching and pricing

Vaiz’s Migration Center supports one-click imports from Jira, Asana, Trello, YouTrack, Notion, Linear, Monday, ClickUp, and Wrike. Pricing starts with a forever free plan for up to 10 users, no credit card required. The Pro plan costs five US dollars per user per month, and the Premium plan costs nine US dollars per user per month. An Enterprise edition with on-premises deployment is available for organisations with data residency requirements. A 30-day free trial covers all paid plans, and startups qualify for a 50 percent discount.

Development pace

Vaiz today releases version 2.84, which introduces calendar integration. Since September 2025, this is the tenth numbered release. The team has recently moved to a two-week release cycle, accelerating from the previous pace of roughly one major update every three weeks. Earlier releases in 2026 delivered an improved UI, Slack integration, Cursor IDE support, and an iOS app with full desktop parity. The public product roadmap is available on the website.

The company’s focus is building a connected workspace where teams can plan, execute, and communicate in one place — without tools that treat employees as subjects of observation. More information is available at vaiz.com.

About Vaiz

Vaiz Ltd was founded in 2024 and is headquartered in Limassol, Cyprus. The company operates a cloud-based work management platform that combines task boards, documents, and automation in one workspace. Vaiz is used by cross-functional teams at startups, product companies, game studios, agencies, and growing businesses.

Related links

LinkedIn: https://www.linkedin.com/company/vaiz/

Media contact

Brand: Vaiz

Contact: Mike Burton

Email: support@vaiz.com

Website: https://vaiz.com

Retail Divide

 

Peter Larsen, a veteran quantitative trader with over three decades of experience on Wall Street, has emerged from retirement to launch Quantum Scalp, a new financial technology firm aimed at democratizing access to institutional-grade algorithmic trading. 

The company announced today that it has secured $100 million in private capital to build a systematic trading platform designed to provide retail investors with tools previously exclusive to investment banks and hedge funds. The funding round included participation from family offices, former industry colleagues, and a sovereign wealth fund.

 

A Career Built on Market Microstructure 

Larsen’s career parallels the evolution of modern electronic trading. He began at Bear Stearns in 1993 as a junior market analyst, joining during the early shift from floor trading to screen-based execution. Throughout the 1990s, Larsen developed statistical models for fixed-income desks, working within the cohort of quantitative analysts who fundamentally rewired the industry’s approach to risk and execution.

In 2001, Larsen moved to Lehman Brothers as a consultant within the firm’s Quantitative Proprietary Trading division. During his tenure, he served as a lead analyst on the Penn-Lehman Automated Trading Project (PLAT). The initiative, a collaboration between Lehman Brothers and the University of Pennsylvania, developed one of the earliest realistic simulators for testing automated trading strategies. PLAT remains a cited reference in academic and industry circles regarding market microstructure and algorithmic execution. 

Larsen retired in 2006, prior to the financial crisis of 2008. For the next fifteen years, he remained active in an advisory capacity, monitoring the widening disparity between institutional and retail trading capabilities. 

Addressing the Intelligence Gap

 

According to Larsen, the post-2010 retail trading revolution reduced costs through commission-free trading and fractional shares but failed to close the “intelligence gap.” 

“Cheap access without an edge isn’t democratization,” Larsen said in an interview at Wyoming. “It often results in capital flowing more efficiently toward institutions that possess superior data and execution tools. Our objective is parity.” 

The catalyst for Larsen’s return to the market was the advancement of artificial intelligence and optimization technologies between 2022 and 2024. Larsen posits that modern transformer-based forecasting and hybrid systems now allow for the compression of capabilities that previously required large quantitative teams. 

Technology and Compliance

 Despite the company name, Quantum Scalp does not utilize quantum computing hardware. Larsen was explicit in clarifying the technology stack to avoid investor confusion. 

“The system is quantum-inspired,” Larsen stated. “We utilize optimization algorithms derived from quantum mechanics, such as simulated annealing variants and tensor-network methods, running on classical GPU infrastructure. Combined with AI-driven signal processing, this allows for portfolio construction and signal weighting at a latency and scale that was not feasible five years ago.”

 The platform operates on three distinct layers:

1.  Signal Layer: Ingests market data, alternative data, and macroeconomic indicators to generate short-horizon forecasts.

2.  Optimization Layer: Applies quantum-inspired algorithms to weight signals and construct positions under risk constraints.

3.  Execution Layer: Manages order routing and slippage, leveraging methodologies originally developed during the PLAT project. 

Industry Skepticism and Regulatory Landscape The launch comes amidst heightened scrutiny of AI-driven retail trading platforms. Regulators in the United States and Europe have increased oversight regarding algorithmic advice given to non-institutional investors. Critics note that previous attempts to democratize quantitative tools, such as early robo-advisors and AI trading startups, have often struggled to match backtested performance in live markets.

Larsen acknowledges the risks inherent in the sector. “We are not selling a guaranteed return,” he said. “Anyone claiming to sell a ‘money printer’ is misrepresenting the product. We are providing the same class of tools, analysis quality, and execution discipline utilized by major desks. How that utility is employed remains the responsibility of the investor.”

 

A Second Act 

At 75, Larsen represents a rare profile in the fintech sector, which is typically dominated by younger founders. Colleagues describe the venture as consistent with his long-standing focus on market structure integrity.

 The firm plans to begin rolling out access to the platform later this year, subject to regulatory compliance and final testing phases. For Larsen, the venture is a corrective measure to a career spent building advantages for the institutional side of the market.

 “I worked for the house for thirty years,” Larsen said. “I intend to provide the players with a system that levels the field.” 

Seoul, Korea – 01/05/2026 – (SeaPRwire) – Global aesthetic brand LemonBottle has strengthened its presence in Latin America after showcasing its products at FACE & BODY 2026 in Mexico.

• Featuring core products including ‘REBOOT,’ focused on fundamental skin recovery and balance.
• Local Mexican physicians share hands-on treatment insights and expertise, engaging in live Q&A sessions
• Discussions on official distribution agreements with local partners, with several contracts successfully signed

FACE & BODY 2026 is a leading international event that brings together professionals from the global aesthetic and medical beauty industries, serving as a platform to share the latest trends, technologies, and products. It is particularly regarded as a key gateway for entering the Latin American market.

 

At the event, LemonBottle presented its core product range, including REBOOT, a treatment focused on skin recovery and balance, alongside its Ampoule Solution for body contouring and Skin Booster, aimed at enhancing skin condition and delivering immediate visible results.

Mexican physicians with hands-on experience using the products took part in live discussions at the booth, sharing treatment insights and answering questions from practitioners. Topics ranged from application techniques to expected results, reflecting growing interest in clinically driven aesthetic solutions. In particular, there was strong interest in the combined skincare program using Ampoule Solution and Skin Booster, as well as continued inquiries about the new product, REBOOT.

In addition, LemonBottle held multiple meetings with local partners during the event, securing several distribution agreements as part of its continued expansion strategy. The company successfully finalized several contracts, laying a solid foundation for practical market entry.

Operated by Korea-based aesthetic company SID MEDICOS, LemonBottle has sold more than 4 millions vials globally and built a network of over 450 official partners. Backed by zero reported cases of adverse effects, LemonBottle is strengthening its position in the aesthetic industry. The brand has particularly gained recognition in key markets including the UK, as well as across Europe and Asia.

Building on the success of this event, LemonBottle plans to accelerate its expansion into the Latin American market. The company aims to rapidly strengthen its market presence through expanded local partnerships and distribution networks, while continuing to introduce next-generation product lines aligned with global trends.

A company representative said the response in Mexico confirmed the region’s strong potential, adding that LemonBottle will continue to expand its local partnerships and distribution network in Latin America. As the global aesthetic market evolves, the brand is focusing on treatments that go beyond short-term results, with increasing emphasis on skin recovery, conditioning and long-term outcomes.

For more information about LemonBottle and its products, please visit the official website and or call them at +82 02-571-1110

Social Links

Whatsapp: https://api.whatsapp.com/send?phone=821095298006

Media contact

Brand: SID MEDICOS (Brand: LemonBottle)

Contact: Media team

Email: partnerships@sidmedicos.com

Website: https://www.lemonbottle.net

Moscow, Russia – 01/05/2026 – (SeaPRwire) – The 2nd Open Dialogue “The Future of the World: A New Platform for Global Growth” took place in Russia, bringing together experts and young researchers from more than 40 countries who proposed ideas on the development of the economy, technology, education, and the environment. The key unifying principle of the event was a focus on people, international cooperation, and the search for new models of global growth through dialogue and the practical implementation of ideas. The large-scale three-day program at the Russia National Centre has concluded, combining expert discussions, presentations by authors of the best essays from around the world, and informal communication with experts.

According to the official remarks, the Open Dialogue has achieved a global footprint that covers the entire planet.

“Experts, business leaders, and researchers from 120 countries took part in the essay and creative works competition, including representatives from Asia, Africa, the Middle East, Europe, Australia, North and South America. All authors and researchers, with diverse experiences and perspectives, were united by a strong and bold idea: to form a shared understanding of the future — the future of a world entering an era of profound structural change. It is evident that no country can develop in isolation, at the expense of other states or to their detriment. Furthermore, modern global challenges require a joint response and collective efforts. This means that the model of global development will be sustainable and fair only if it is based on the principles of equality and mutual respect, and takes into account the interests of all countries,” the honorary guest of the event stated.

According to the Russian leader, a multipolar architecture of global development is being formed before our eyes. Within it, an important role is played by states that understand and value national sovereignty.

The results of the large-scale event were summarized by Russian economist Maxim Oreshkin: “Russia, in a number of areas, is an advanced country in terms of the development of digital platform solutions. Our approach is one of joint development. When Russian digital platforms enter other countries’ markets, they bring data localization, local partner involvement, training for local personnel, and the development of their own competencies in platform solution development. Russia comes to develop together, not to collect colonial rent from countries that lack access to technological solutions. We are in favor of developing together.”

Maxim Oreshkin noted that the reach of the Open Dialogue will continue to grow each year. According to him, significant attention is being paid to the stage of implementing the ideas proposed in the essays. A mentorship format has been introduced — Russian businesses and international companies are beginning to work with essayists, involve them in their projects, and help bring their ideas to life.

At the 2nd Open Dialogue, the best essay authors were identified in four areas: “Investing in People,” “Investing in Connectivity,” “Investing in Technology,” and “Investing in the Environment.”

The winner in the “Investing in Technology” track was Aya Arfaoui, a student of Mohammed V University in Rabat, Morocco. She raised the issue of the digital sovereignty of developing countries. According to her, international institutions do not provide sufficient influence in regulating the digital space.

Solomon Gardie, a postgraduate student at Addis Ababa University in Ethiopia, became the winner in the “Investing in Connectivity” track. His essay focused on connectivity and the mobility of sovereign data. He proposed a system in which data is processed and anonymized before cross-border transfer, and only in this form can it be used for the common good. He also noted that, within cooperation in the BRICS+ framework, one of the first areas could be healthcare, particularly epidemiological monitoring and disease control.

In the “Investing in the Environment” track, the winner was Soumya Bhowmick, a research fellow at the Observer Research Foundation (India). In his presentation, he stated that for almost 100 years, the world has focused on measuring GDP, which does not reflect a country’s real wealth.

The winner of the “Investing in People” track was Lubinda Haabazoka from Zambia. In his speech, he noted that for real convergence among countries of the Global South, not only declarations of multipolarity are needed, but also practical changes in key systems of interaction — primarily in education, which directly affects opportunities for cooperation and knowledge exchange.

The future should be built around the individual, their health, agency, and a long, meaningful life, rather than around technologies and outdated systems, believes Dr. Selina Neri, co-founder, CEO, and dean of Future Readiness Academy (UAE), and an expert of the 2nd Open Dialogue in the “Investing in People” track. According to her, this requires new approaches to education, work, and technology development that focus on human flourishing, sovereignty, and the practical implementation of ideas rather than copying ineffective models.

More than 1,600 authors from all continents submitted their works to participate in the 2nd Open Dialogue. Seventy-five essay authors hold academic degrees. The conclusions drawn from the discussions will be reviewed at the St. Petersburg International Economic Forum and will be reflected in its business program. Essayists and experts will also be engaged in activities within the BRICS platform and involved in preparations for the Russia–Africa Summit.

Social Links

Telegram: https://t.me/gowithRussia

Media Contacts

Brand: Russia National Centre

Contact: Media team

Email: pressa@russia.ru

Website: https://en.russia.ru 

Mahe, Seychelles – 30/04/2026 – (SeaPRwire) – Excent Capital, the global multi-asset trading platform that builds and owns its technology, announces a major update to its platform. The release introduces a redesigned chart, new tools, drawing instruments, on-chart position management, and improved MAM capabilities.

Built Different, Delivered Faster

In an industry where most brokers rely on white-label solutions and third-party platforms, Excent Capital has taken a different path. The company develops its platform internally, maintaining direct control over performance, execution quality, and product evolution.

That structure allows the team to move faster, releasing features frequently, responding directly to partner feedback, and refining the trading experience. This update reflects that approach in practice.

A Smarter, More Capable Chart

The redesigned layout introduces a new side toolbar with streamlined access to Fibonacci tools, drawing instruments, and zoom controls. Navigation has also been refined, with gestures such as pinch-to-zoom, drag movement, and vertical swipe to adjust candle height, allowing traders to move through price action with greater precision.

New drawing tools have been integrated directly into the chart, including circles for marking key zones, trend lines across price action, text labels, and a date/price range tool that measures movement across both time and price. A five-wave pattern tool has also been added, enabling traders to map Elliott Wave structures more efficiently.

The Fibonacci retracement tool has been updated with improved precision and expanded visual customisation across both desktop and mobile.

Positions Managed Directly on the Chart

Open positions are now displayed directly on the chart at their entry price, with profit and loss, lot size, and spread cost visible in real time.

From the same view, traders can set Take Profit and Stop Loss levels or close positions without navigating away. The result is a more integrated workflow, where analysis and execution coexist within a single interface.

A Consolidated Mobile Portfolio View

Mobile users now have access to a unified Portfolio view, bringing positions and orders into a single dedicated space.

Orders are organised by status, with count indicators and collapsible groupings, while the full account history remains easily accessible. The update aligns the mobile experience more closely with the desktop environment, reducing friction between devices.

Expanded MAM Capabilities

Excent Capital’s MAM Account is designed for synchronised execution across all linked Echo accounts.

With this update, users gain access to a full position breakdown for each master trade, including detailed metrics, linked sub-positions, and direct actions such as closing or hedging from a single panel.

Echo Finance has also been integrated into a dedicated Dashboard section, where users can monitor aggregated transactions, review linked positions, and access detailed information for each connected account.

Made For Traders, By Traders

Behind the platform is a dedicated support team with direct knowledge of the product. The proximity between development and support allows for faster resolution, clearer communication, and continuous iteration based on real user interaction. Traders operate across FX, equities, indices, commodities, cryptos and ETFs within a single environment designed for consistency and reliability.

Excent Capital continues to expand its platform and infrastructure, with new products and markets already in development.

Create the free demo account and explore the platform: https://excent.capital/

About Excent Capital

Excent Capital Ltd. develops and maintains its own proprietary trading technology, giving clients direct access to a platform built and controlled entirely in-house. With five years of sustained growth and a presence across multiple regions, the company has established itself as a reliable and innovative force in the trading industry. Excent Capital continues to scale its platform while maintaining full control over its infrastructure, technology, and service delivery, ensuring that performance, security, and client experience remain at the highest standard.

Contact Information

Brand: Excent Capital

Contact: Ryccielli Ongaratto, Marketing Manager

Email: support@excent.capital

Website: https://excent.capital

The gate arch of the “Guangdong Goods Go Global: Zhongshan Products in Malaysia” event in Kuala Lumpur on April 25, 2026.

On the morning of April 25, the China (Zhongshan)–Malaysia (Kuala Lumpur) Investment Promotion & Exchange Conference, together with the “Guangdong Goods Go Global: Zhongshan Products in Malaysia” event, officially kicked off at Pavilion Bukit Jalil in Kuala Lumpur.

Video: https://youtu.be/hdOltkn6Taw

This marks the first time that the “Guangdong Goods Go Global” initiative has gone overseas for an on-site, offline exhibition and sales event since its launch.

Themed “Zhongshan Premium Products, Trade Connecting Southeast Asia,” the two-day event established a high-standard offline exhibition and sales platform for Zhongshan’s premium products. Key categories included smart home appliances, lighting fixtures, hardware locks, daily necessities, smart equipment, and smart physiotherapy robots.

More than 70 high-quality enterprises from Zhongshan, including TCL, Changhong, and Vatti, showcased over 300 distinctive products. Among them, more than 20 companies participated in on-site sales, while 30 companies joined the exhibition display, effectively integrating sales promotion with brand exposure and market expansion.

The event featured 11 standard booths and 9 special booths, forming a themed exhibition area titled “Intelligent Manufacturing Zhongshan.” In addition, dedicated display boards for “Charming Zhongshan” and “Cultural Tourism Zhongshan” highlighted the city’s manufacturing strength, urban development, and unique cultural and tourism resources as a renowned hometown of overseas Chinese.

The exhibition also established a comprehensive marketing system integrating domestic and international operations across multiple platforms, achieving strong online-offline synergy. Shopee, a leading e-commerce platform in Malaysia, was invited to engage in face-to-face exchanges with participating enterprises, introducing its platform services, onboarding policies, and channel resources.

During the event, it was officially announced that the “Malaysia (Johor Bahru)–China (Zhongshan) Famous and High-Quality Products Trade Centre” will be established in Malaysia. A plaque-awarding ceremony was also held for two Zhongshan-based enterprises.

This initiative signifies that Zhongshan enterprises now have a forward base in Malaysia for regular exhibitions, sales activities, and business matchmaking.

Beyond showcasing products, the event also highlighted Zhongshan’s industrial ecosystem and business environment. The Zhongshan Investment Promotion Bureau presented the city’s investment climate and appointed representatives from the Malaysian business community as investment advisors.

This initiative not only creates new opportunities for Zhongshan’s manufacturing sector to expand globally through trade cooperation, but also offers overseas investors a comprehensive understanding of Zhongshan’s favorable business environment.

“An increasing number of businesspeople, impressed by Zhongshan’s industrial and supply chain advantages, are visiting the city after seeing its products,” said Jiang Ji, Party Secretary of the Zhongshan Investment Promotion Bureau.

Jiang noted that Zhongshan has innovated its investment promotion mechanisms by leveraging the resources of Chinese embassies and consulates, business institutions, and key overseas Chinese enterprises through the “Guangdong Goods Go Global” platform.

These efforts have enabled Zhongshan products to confidently expand overseas while also attracting waves of Southeast Asian Chinese entrepreneurs to return and invest, continuously boosting foreign investment in the city.

The event is expected to accelerate the transformation of cooperation between Zhongshan and ASEAN from traditional trade to a more integrated model of two-way investment, industrial collaboration, and long-term win-win partnerships. It will facilitate the entry of more high-quality Zhongshan products into Southeast Asia while encouraging more Southeast Asian enterprises to invest in Zhongshan, fostering a virtuous cycle of economic and trade development.

SHENZHEN, CHINA – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that, the Group through its wholly-owned subsidiary entered into an exclusive commercialization and supply agreement (the “Agreement”) with Pharmacosmos A/S for Iron Isomaltoside Injection (“Monofer^®”) and Iron Dextran Injection (“Cosmofer^®”) recently. In accordance with the Agreement, the Group has obtained an exclusive right to commercialize the products in the People’s Republic of China (for the purpose of this Agreement, excluding the Hong Kong Special Administrative Region, the Macau Special Administrative Region and Taiwan region). Pharmacosmos A/S will continue to manufacture and supply the products. The cooperation term shall be fifteen years from the effective date stipulated in the Agreement, which may be extended upon mutual agreement between the parties prior to expiry.

 

The two intravenous iron therapies under this cooperation are both originator products that have been approved for marketing in China and included in the China’s National Reimbursement Drug List (NRDL). Among them, Monofer^® is an exclusive drug and the first third-generation intravenous iron therapy approved for marketing in China. It features an innovative and more stable matrix-like nanostructure and provides a superior safety profile^[1]. Its single-dose full iron replenishment significantly reduces the number of infusions, enables faster improvement in hemoglobin levels and enhances clinical convenience. Another product, Cosmofer^®, is currently the only intravenous iron therapy included in Category A of the NRDL and also the only one included in the National Essential Medicines List (NEML). With many years of accumulated clinical use, its efficacy and safety have been supported by accumulated clinical experience and published data.

 

The above two products will form a comprehensive intravenous iron product portfolio covering all channels and treatment scenarios, which can support meeting the clinical needs of different levels of healthcare institutions and different types of iron deficiency anemia (IDA) patients, providing more diversified, safe and effective treatment options for patients. Patients with iron deficiency (ID) and IDA are widely distributed across multiple clinical departments, including gastroenterology, cardiology, nephrology, obstetrics and gynecology, and orthopedics, which are all key specialty areas of the Group. The addition of the two products will generate efficient synergies with the Group’s existing marketed products in expert resources and academic promotion network, further strengthening the Group’s overall competitiveness in the field of anemia treatment, and is expected to have a positive impact on the Group’s performance.

 

More information about Monofer^®

Monofer^® was approved on 30 January 2021 for the treatment of iron deficiency in patients where oral iron preparations are ineffective, cannot be used, or where there is a clinical need for rapid iron supplementation. In 2023, Monofer^® was included in the NRDL as a Category B reimbursable drug. Monofer^® consists of nanoparticles with a stable, matrix-like structure composed of interchanging layers of iron atoms and short, linear isomaltose carbohydrates. This structure enables controlled iron release with low levels of labile iron, contributing to a favourable safety profile, including a low risk of hypersensitivity reactions and hypophosphatemia. Monofer^® can be administered as a high-dose infusion of 1,000 mg or more in a single visit, whereas older therapies such as iron sucrose typically require repeated administrations of 100 to 200 mg. This enables full iron repletion in one treatment, reducing the need for multiple infusions, lowering the burden on patients and healthcare systems, and increasing infusion capacity. At the same time, the low risk of hypophosphatemia helps avoid complications such as fractures and supports recovery from fatigue, a key symptom of iron deficiency anaemia.

 

More information about Cosmofer^®

Cosmofer^® is a second-generation low-molecular-weight iron dextran injection. It was approved for marketing in Mainland China in 2003 and is indicated for patients with iron deficiency who cannot take oral iron preparations (such as those who are intolerant to oral iron or have unsatisfactory therapeutic outcomes). Cosmofer^® also allows single-dose high-dose iron repletion. With many years of accumulated clinical use, its efficacy and safety have been supported by accumulated clinical experience and published data. Its dual status as a Category A NRDL-listed product and NEML supports its core role in iron supplementation in primary healthcare settings.

 

About Iron Deficiency and Iron Deficiency Anemia

ID and IDA are global health issues that commonly affect children, premenopausal women (particularly pregnant women) and the elderly. These conditions may impair the function of multiple organ systems, leading to a series of health problems such as growth retardation, behavioral disorders, cognitive impairment, reduced physical capacity, and peri-natal and peri-operative complications. They also significantly affect the prognosis of chronic diseases such as gastrointestinal diseases, chronic kidney disease, heart failure and tumors^[2]. More than 1 billion people live with iron deficiency anaemia^[3], making it one of the leading contributors to the global burden of disease^[4]. Data from the Fourth National Nutrition Survey in China indicate that the prevalence of IDA among Chinese residents is 20.1%^[5]. However, both patients and healthcare professionals have insufficient awareness of the disease. Less than 20% of patients with mild anemia receive diagnosis and treatment, while only about 50% of patients with severe anemia receive appropriate diagnosis and treatment^[2]. This indicates significant underdiagnosis and undertreatment of ID/IDA. Iron supplementation is the standard treatment for ID/IDA and includes oral iron therapy and intravenous iron therapy. Intravenous iron therapy is an important option for patients who cannot tolerate oral iron, have inadequate response to oral therapy, require rapid iron repletion, or prefer full iron supplementation within one to two administrations^[1,2,6]. However, due to insufficient awareness of IDA, patient adherence issues, hospitalization constraints, infusion convenience, and safety concerns regarding intravenous iron therapies, the clinical use of intravenous iron in China remains relatively conservative. A Chinese real-world study shows that the average total dose of iron sucrose used in IDA patients was approximately 511 mg, which was significantly lower than the target dose of 1,000 mg^[2]. There is therefore a significant clinical need for intravenous iron therapies that offer high safety, strong demonstrated efficacy and single-dose full iron repletion. Monofer^® and Cosmofer^® together establish a comprehensive intravenous iron product portfolio covering multiple treatment scenarios, providing tiered treatment options for patients with iron deficiency anemia.

 

About Pharmacosmos A/S

Pharmacosmos A/S is a global leader in carbohydrate chemistry and innovative treatments for iron deficiency and iron deficiency anemia. Leveraging its deep expertise in carbohydrate chemistry and cell cycle biology, the company is committed to developing innovative therapies to address unmet patient needs, with a particular focus on iron metabolism and hematology-related diseases. Pharmacosmos A/S was founded in 1965 and is headquartered in Denmark, and employs more than 700 specialists from the United Kingdom, Ireland, the Nordic countries, Germany, the United States, Canada and China. With excellent product quality and strong clinical value, its core iron therapy products have been approved and widely used in multiple countries and regions worldwide, establishing strong technological capabilities and a solid market reputation.

 

About CMS

CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.

 

CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.

 

CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardiovascular-kidney-metabolic/gastroenterology/ophthalmology/skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.

 

Reference:

1. Chinese Pharmacological Society Professional Committee of Drug‑induced Diseases, Guangdong Pharmaceutical Association. Expert consensus of clinical application and pharmaceutical care for intravenous iron agents (2024) [J]. Adverse Drug Reactions Journal, 2025, 27(3): 129-141. DOI: 10.3760/cma.j.cn114015⁃20240929⁃00070
2. Liao Minjing, Zhang Liansheng. Standardized diagnosis and treatment of iron deficiency and iron‑deficiency anemia [J]. Chinese Journal of Internal Medicine, 2023, 62(6): 722-727. DOI: 10.3760/cma.j.cn112138-20230210-00074.
3. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2020. Available from http://ghdx.healthdata.org/gbd-results-tool.
4. Pasricha SR, Tye-Din J, Muckenthaler MU, Swinkels DW. Iron deficiency. Lancet. 2021 Jan 16;397(10270):233-248.
5. Li Lijuan, Zhang Liansheng. Considerations on the standardized diagnosis and treatment of iron‑deficiency anemia [J]. National Medical Journal of China, 2021, 101(40): 3266-3270. DOI: 10.3760/cma.j.cn112137-20210609-01319.
6. Red Blood Cell Disease (Anemia) Group, Chinese Society of Hematology, Chinese Medical Association. Multidisciplinary expert consensus on the diagnosis, treatment and prevention of iron deficiency and iron deficiency anemia (2022 edition) [J]. National Medical Journal of China, 2022, 102(41): 3246-3256. DOI: 10.3760/cma. j.cn112137-20220621-01361.

 

CMS Disclaimer and Forward-Looking Statements

This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.

This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.

 

Media Contact

Brand: China Medical System Holdings Ltd.

Contact: CMS Investor Relations

Email: ir@cms.net.cn

Website: https://web.cms.net.cn/en/home/

Hong Kong – April 27, 2026 – (SeaPRwire) – As one of the most economically dynamic regions in the world, the linkage between Asia’s core business hubs is becoming increasingly close. To adapt to this trend and help multinational enterprises achieve highly efficient cross-regional PR synergy, SeaPRwire (https://seaprwire.com) announced today that it has officially completed a comprehensive strategic upgrade of its “one-stop” PR communication links across Japan, South Korea, Hong Kong, and Singapore.

Japan, South Korea, Hong Kong, and Singapore, as Asia’s four major economic and financial engines, each possess unique media ecosystems and business cultures, yet they are simultaneously the preferred choices for many multinational enterprises setting up Asia-Pacific headquarters. In the past, when enterprises conducted PR placements in these regions, they often had to interface with different local agencies, which not only incurred high communication costs but also made it difficult to guarantee brand tonality consistency. The core of SeaPRwire’s upgrade this time is to break down geographical barriers and integrate top-tier media resources from these four regions in a modular, one-stop manner.

Through the upgraded full-featured workbench, corporate PR teams only need to use a single background to simultaneously assign and monitor news distribution tasks in these four countries and regions. Based on the communication goals set by the enterprise, the AI system automatically coordinates the distribution rhythm of media across the four regions. Whether releasing strategies in Singapore, synchronizing with capital markets in Hong Kong, or conducting localized product promotions in Japan and South Korea, millisecond-level cross-border synergy and voice resonance can be achieved.

“Business competition in Asia has long ceased to be a solo fight; it is a contest of regional synergy,” emphasized SeaPRwire’s VP of Product. “By opening up the links across Japan, South Korea, Hong Kong, and Singapore, we aim to provide enterprises with a ‘PR highway network’ covering Asia’s core economic circles. Enterprises can easily leverage the attention of mainstream media across the entirety of Asia as simply as distributing drafts locally.”

About SeaPRwire

SeaPRwire is Asia’s leading AI-driven earned media management platform, purpose-built to empower PR and communications professionals. Through its flagship Branding-Insight Program, the platform connects clients to over 80,000 journalists and an influencer matrix reaching 300 million followers. Leveraging advanced AI, SeaPRwire helps users identify media targets, personalize pitches, and measure PR impact across key APAC markets, including Japan, China, Korea, and Southeast Asia.

Media Contact

Company: SeaPRwire

Contact: Media Relations Team

Email: cs@seaprwire.com

Website: https://seaprwire.com